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Introduction
Implantation in humans and other mammals is a critical period during which embryo mortality rates are high (reviewed in Wilmut et al. (1986) ). Prostaglandins (PGs) are key factors in the development and maintenance of pregnancy because inhibition of their synthesis leads to termination of gestation before implantation in many species including pigs (Waclawik 2011) . PGF2α is the main luteolytic factor in the female reproductive tract of most mammals (McCracken et al. 1999) . Acting on its receptor (PTGFR) localized in luteal cells, it invokes a process of regression in the corpus luteum (CL). PTGFR is coupled to G q -protein, and its activation results in elevation of the intracellular Ca 2+ concentration mediated by PKC phosphorylation (Bos et al. 2004) . PGF2α acting via PTGFR may also stimulate the MAPK1/3 pathway, resulting in elevated expression of angiogenic factors in endometrial pathologies (Sales et al. 2005) .
Owing to the luteolytic effect of PGF2α on the CL, exogenous administration of this PG decreases pregnancy rates or even terminates early pregnancy in many species such as humans, cattle, pigs, and dogs (Podany et al. 1982 , Pajor & Zsolnai 1984 , Romagnoli et al. 1993 , Seals et al. 1998 , Lemaster et al. 1999 . However, elevated amounts of PGF2α in the uterine lumen and/or its increased endometrial synthesis are observed during the implantation period in various mammals with different types of placentation: humans (Wang et al. 2010 , Vilella et al. 2013 , pigs (Zavy et al. 1980 , Waclawik et al. 2006 , cattle (Ulbrich et al. 2009 ), dogs (Kowalewski et al. 2014) , and rats (Kennedy et al. 2007) . Interestingly, our studies revealed that during the implantation and early placentation period, expression of PGF2α synthase increases in both the porcine endometrium and conceptus (embryo with extraembryonic membranes; Waclawik et al. 2006 Waclawik et al. , 2007 . The phenomenon of increased PGF2α amounts in the uterine lumen can be partially explained by the concept of maternal recognition of pregnancy, indicating that the porcine conceptus signal (estradiol-17β (E 2 )) changes PGF2α secretion from an endocrine into an exocrine manner (Bazer et al. 1977 , Zavy et al. 1980 . Intriguingly, our recent study demonstrated elevated expression of PTGFR protein in the endometrium during the implantation period (Kaczynski & Waclawik 2013) . Apparently, contradictory reports on beneficial (Dorniak et al. 2012 ) vs detrimental (Podany et al. 1982 , Pajor & Zsolnai 1984 , Romagnoli et al. 1993 , Seals et al. 1998 , Lemaster et al. 1999 ) roles of PGF2α on pregnancy establishment prompted us to further investigate its actions on the uterus during the implantation period in a porcine model. Key questions are as follows: Is PGF2α need for the endometrium during the implantation period? What role does it exert when it is secreted in an autocrine and/or paracrine manner by the conceptus and uterus?
As in pathological conditions PGF2α signaling mediates the expression of angiogenic factors in human endometrial cells (Sales et al. 2005) , we propose that an increased level of PGF2α in the uterine lumen during implantation could be involved in angiogenesis. Herein, we hypothesize that the conceptus by secreting its signals modulates endometrial expression of PTGFRs and that PGF2α acting in an autocrine/paracrine manner through its receptors in the endometrium promotes establishment of the proper environment for development and maintenance of pregnancy. The main aim of this study was to determine the role of PGF2α in early pregnancy using the porcine model. The objectives of this research were: (i) to determine the effect of the conceptus and its signal (E 2 ) on endometrial PTGFR gene and protein expression using in vitro and in vivo models; (ii) to characterize localization of the PTGFR within the uterus; (iii) to identify intercellular signaling pathways activated by PGF2α in endometrial cells and to determine the effects of PGF2α on synthesis and secretion of vascular endothelial growth factor A (VEGFA) by the porcine endometrium in vitro; (iv) to investigate the influence of PGF2α on endometrial endothelial cell proliferation; and (v) to determine the effect of PGF2α on the expression of factors involved in extracellular matrix (ECM) and tissue remodeling and embryo-maternal communication in the endometrium in vitro.
Materials and methods
All procedures involving the use of animals were conducted in accordance with the national guidelines for agricultural animal care and were approved by the Animal Ethics Committee, University of Warmia and Mazury in Olsztyn, Poland, permission no. 17/2008 , 32/2008 , and 36/2012 
Experiment 1: effect of conceptus on PTGFR gene and protein expression in endometrium in vivo
Local and systemic effects of the conceptus on PTGFR gene and protein expression were studied using a porcine in vivo model of unilateral pregnancy. Although unilateral pregnancy cannot be maintained in pigs, it can be used at the early stage of pregnancy to study the direct and systemic effects of conceptuses on the uterus (Christenson et al. 1994 , Wasielak et al. 2009 ). In our experiment, prepubertal crossbred gilts (n = 24) of similar age (6-6.5 months), weight (100-110 kg), and genetic background were subjected, under general anesthesia, to a surgical procedure in order to isolate one uterine horn from the cervix. After 6-9 days of recovery, gilts were treated hormonally with 750 IU equine chorionic gonadotropin (eCG) (Folligon; Intervet, Boxmeer, The Netherlands) and 500 IU human chorionic gonadotropin (hCG) (Chorulon; Intervet) given 72 h later to induce estrus. Between days 12 and 14 of the estrous cycle gilts were injected with 10 mg PGF2α (Dinolytic; Pfizer). After 16 h later, 10 mg of PGF2α were injected simultaneously with 750 IU eCG pregnant mares serum gonadotropin (Folligon; Intervet). After 72 h, 500 IU hCG (Chorulon; Intervet) were given intramuscularly. Animals assigned to pregnant groups were artificially inseminated 24 and 48 h after hCG injection. The day of second insemination was defined as the first day of pregnancy. After insemination, conceptuses were developing only in the intact horn. Animals were then killed on day 11 (n = 6) or day 14 (n = 6) of pregnancy because these are the periods that correspond with the maternal recognition of pregnancy and the initial stage of implantation in pigs respectively. The control group consisted of gilts that underwent the same procedures, except of insemination (gilts on day 11 (n = 6) and day 14 (n = 6) for the estrous cycle). After killing, uterine horns of all gilts were washed with 20 mL PBS. Pregnancy was confirmed by the presence of conceptuses, which were flushed only from the connected uterine horn of pregnant animals. The ovulation rates, in relation to the number of corpora lutea, did not differ between analyzed groups: gilts on day 11 of the estrous cycle, day 11 of pregnancy, day 14 of the estrous cycle, and day 14 of pregnancy (Supplementary  Table 1 , see section on supplementary data given at the end of this article). Fertilization rate was presented for pigs on day 11 of pregnancy (Supplementary Table 1 ). In day 14 of pregnancy group, conceptuses possessed filamentous forms that are very fragile and not possible to flush in one piece. For this group, the number of conceptuses was not counted and therefore fertilization rates were not possible to present.
Endometrial samples were dissected from myometrium and snap-frozen in liquid nitrogen and then stored at −80°C until analyzed for gene and protein expression. Local effects of the conceptus on PTGFR expression were studied by comparison of PTGFR mRNA and protein levels in each gilt in endometrial samples from the horn in which conceptuses were present (intact horn) to its expression in endometrial samples from the isolated horn. Systemic effects of the conceptus on the expression of PTGFR were studied by comparison of PTGFR mRNA and protein levels in endometrial samples of intact and isolated horns from the pregnant group to the respective endometrial expression in the control cyclic group on day 11 or 14 after estrus.
Experiment 2: effect of E2 on endometrial PTGFR expression in vitro

Incubation of luminal epithelial and stromal cells of endometrium with E2
Luminal epithelial (LE) and stromal (ST) cells were isolated as described previously (Kaczynski & Waclawik 2013 ) and grown in Medium 199 with antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin) supplemented with 1% (w/v) BSA, 10% (v/v) NCS, 10 nM E 2 , and 100 nM progesterone. After reaching 70-90% confluency, cells were treated with E 2 (100 nM) or control (vehicle) and incubated for 24 h at 37°C in a humidified atmosphere containing 95% air and 5% CO 2 . After incubation, cells were lysed with Fenozol buffer (A&A Biotechnology, Gdansk, Poland), harvested, and stored at −80°C until PTGFR gene expression analysis.
Incubation of endometrial explants in vitro with E2
Endometrial explants collected from gilts (n = 7) on day 12 of the estrous cycle were prepared as described previously (Waclawik et al. 2009) . After 2 h of preincubation, explants were treated in duplicates as follows: E 2 (1, 10, and 100 nM) or control (vehicle -M199 with 0.1% v/v ethanol) for 24 h at 37°C in a humidified atmosphere of 5% CO 2 in air. Then, explants were snap-frozen in liquid nitrogen and stored at −80°C until protein and gene expression analyses.
Experiment 3: effect of E2 and PGE2 on PTGFR mRNA and protein expression in endometrium in vivo
Effects of E 2 and/or PGE2 administered alone or simultaneously were studied using a porcine in vivo model. Crossbred gilts at the same age and genetic background, after second natural estrous cycle underwent estrus synchronization according to the procedure described in Experiment 1. On days 8-9 of the third estrous cycle, animals underwent surgery in which both uterine horns were cannulated. The intrauterine cannula was perforated along its length in an attempt to simulate hormone delivery by conceptuses as reported in (Ford et al. 1982) with some modifications. The cannula was introduced into the uterine lumen at a distance of 10-15 cm from the isthmus and it did not cover whole uterine horn. Mixing between uterine horns was excluded. In the control group, each horn received intrauterine vehicle (5 mL of 1% v/v ethanol saline) infusions. In the experimental group, doses of hormones used were similar to those previously published (Ford et al. 1982 , Akinlosotu et al. 1986 ). Randomly selected horns within each gilt received hormonal infusions: E 2 (833 ng or 33.3 µg per infusion), PGE2 (200 µg per infusion), or E 2 (833 ng or 33.3 µg per infusion) simultaneously with PGE2 (200 µg per infusion) whereas the contralateral horn received only vehicle infusions. Treatments were administered every 4 h for 24 h on days 11-12 after the onset of estrus. Endometrial samples were dissected from myometrium and snap-frozen in liquid nitrogen and then stored at −80°C until gene and protein expression analyses. Uteri with inflammatory changes and/or with fluid accumulation were not included in experiments. Local effects of E 2 , PGE2, or E 2 together with PGE2 on PTGFR expression in endometrium were studied by comparison of PTGFR mRNA and protein levels in the endometrial samples from the hormone-treated horn to its expression in the samples from the vehicle-treated horn of each gilt. Systemic effects of E 2 and PGE2 on the expression of PTGFR were studied by comparison of PTGFR mRNA and protein levels in endometrial samples from the experimental group to the levels in the control group (vehicle infusions into both horns).
Experiment 4: immunolocalization of PTGFR protein in uterus
Immunohistochemical localization of PTGFR protein in porcine endometrium on days 12 and 15 of pregnancy and on day 12 of the estrous cycle was performed as described previously with some modifications (Kowalewski et al. 2006) . Incubations with primary antibody (Table 1) were performed overnight at 4°C. Antiserum-specific isotype controls (rabbit IgG) at the same dilution and protein concentration as the primary 
Experiment 5: effect of PGF2α in endometrium in vitro
Incubation of LE cells of endometrium with PGF2α: phosphorylation studies LE cells isolated as described in Experiment 2 were pretreated for 1 h with 25 µM PD098059 (a pharmacological inhibitor of MAPK-kinases; Sigma-Aldrich) or vehicle. Subsequently, cells were incubated with PGF2α (10 nM-1 µM; Sigma-Aldrich) or control (vehicle) for 10 min. Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% v/v Triton X-100, 1% w/v SDS, 0.5% w/v sodium deoxycholate, and 1 mM EDTA) containing protease and phosphatase inhibitor cocktail (SigmaAldrich) and stored at −80°C until western blot analysis.
Incubation of endometrial explants with PGF2α and fluprostenol
To study the effect of PGF2α and its analog -fluprostenolon VEGFA secretion in vitro, endometrial explants prepared as described in Experiment 2 were incubated for 24 h at humidified atmosphere of 5% CO 2 in air with the following treatments: control (vehicle), M199 with PGF2α (100 nM and 1 µM), and fluprostenol (100 nM and 1 µM; Sigma-Aldrich) in the presence/ absence of 50 μM AL8810, 50 μM LY294002, 50 μM PD98059, and 50 μM SQ 22,536 (PTGFR inhibitor, phosphatidylinositol-3-kinase inhibitor, MAPK1/3 kinases inhibitor and adenylyl cyclase inhibitor respectively; Sigma-Aldrich). After incubation, collected culture media (CM) were frozen for further analyses (RIA and proliferation assay). Conditioned media from incubation of endometrial explants treated with vehicle were defined as C-CM, whereas conditioned media from incubation of endometrial explants treated with PGF2α were defined as PGF-CM. Endometrial explants were rinsed twice with sterile PBS and snap-frozen in liquid nitrogen and then stored at −80°C until gene expression analyses. Expression of VEGFA was analyzed by real-time RT-PCR. Our preliminary studies (A Waclawik and P Kaczynski, unpublished observations) indicate that another PG (PGE2), which is secreted by the endometrium and the conceptus, regulates the expression of biglycan (BGN), interleukin 1α (IL1A), IL6, matrix metalloproteinase 9 (MMP9), and transforming growth factor β3 (TGFB3) genes. In this study, we determined by real-time RT-PCR whether endometrial expression of these genes can be regulated by PGF2α.
Experiment 6: effect of PGF2α on endometrial endothelial cell proliferation
Isolation of endothelial cells from porcine endometrium
Uteri were collected from gilts (n = 6) on day 12 of the estrous cycle and killed at the local abattoir. Uterine horns were cut into 10 cm length and rinsed in ice-cold, sterile PBS containing antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin). Endometrial tissue was separated from the myometrium and digested in 0.48% Dispase (Sigma-Aldrich) in Hanks' balanced salt solution (Ca 
Characterization of primary endometrial endothelial cells by immunolocalization of VE-cadherin and von Willebrand factor
As VE-cadherin (CDH5) and von Willebrand factor (VWF) are markers of endothelial cells, their expression was examined to confirm homogeneity of the isolated cells. Primary endothelial cells were grown to confluency on 13 mm sterile plastic coverslips (Thermo Fisher Scientific) in 24-well culture plate. Cells were then fixed in ice-cold methanol at −20°C for 10 min. Immunocytochemistry was performed as described previously (Chrusciel et al. 2011 ) with some modifications. Detailed information including the source of the antibodies and their concentration is presented in Table 1 . In control staining, primary antibodies were replaced with normal goat IgG (for CDH5) and normal rabbit IgG (for VWF) diluted, respectively, to the antibody concentrations.
Proliferation assay
PEE cells and the immortalized swine umbilical vein endothelial cell line (G1410; Chrusciel et al. 2011) were assigned for proliferation assay. Cells (4 × 10 4 PEE or 2 × 10 4 G1410 cells/ well) were seeded in 96-well culture plates. Following attachment, at the 45-50% confluency, cells were pretreated with 5 μM AAL993 (inhibitor of VEGF receptors: FLT1, KDR, and FLT4) or vehicle. After pretreatment, cells were treated with conditioned media from Experiment 5 (C-CM, PGF-CM, PGF-CM+AL8810, or PGF-CM+SQ22,536) diluted three-fold with M199, in the presence/absence of 5 μM AAL993. VEGFA (50 ng/mL) in M199 and 20% (v/v) of NCS in C-CM were used as positive control treatments. As we observed the nonspecific effects of PGF-CM and LY294002 or PGF-CM and PD98059 on endothelial cells, they were excluded from further experiments. In the separate experiment, we examined the direct effect of PGF2α and fluprostenol on endothelial cell proliferation. Cells were treated with PGF2α (100 nM and 1 μM) and fluprostenol www.reproduction-online.org
Reproduction (2016) 151 [539] [540] [541] [542] [543] [544] [545] [546] [547] [548] [549] [550] [551] [552] in the presence/absence of AL8810 or control (vehicle). The effects of AAL993, AL8810, and SQ22,536 alone, present in the conditioned media, were also tested. After 48 h of treatment, proliferation was determined using the Cell Titer 96 Aqueous One Solution Proliferation Reagent (Promega) according to the manufacturer's instructions. Experiments were repeated six times (PEE) or five times (G1410) in duplicate. Fold difference was determined by dividing the absorbance obtained by PGF-CM-treated cells by the absorbance obtained by C-CM treated cells.
Effect of AAL993 on HIF1A protein expression in G1410 cells
As AAL993 (inhibitor of VEGF receptors: FLT1, KDR, and FLT4) may suppress HIF1A in vitro and HIF1A can exert its effects also under normoxia, we decided to determine the expression of HIF1A protein in order to assess the basic capability of AAL993 to affect our results. G1410 cells were cultured on six-well plates (Thermo Fisher Scientific). After reaching 80-90% confluency, they were incubated with control, C-CM, or PGF-CM without/with AAL993 (5 μM) for 48 h in a humidified atmosphere containing 5% CO 2 and 95% air. After incubation, cells were lysed in RIPA buffer. Experiments were repeated three times. Expression of HIF1A was analyzed by western blot.
Western blot
Western blot analysis for protein expression in samples from in vivo models and in vitro experiments was performed as described previously (Kaczynski & Waclawik 2013 . Briefly, equal amounts of protein samples (40 µg for PTGFR, 18 µg for MAPK1/3, or 35 µg for HIF1A) from endometrial tissue homogenates or cell lysates were separated on 10% (PTGFR and MAPK1/3) or 8% (HIF1A) SDS-PAGE. Proteins were electroblotted onto 0.45 µm PVDF membrane. After blocking, blots were incubated overnight at 4°C with primary antibodies (Table 1) and afterward with 1:20,000 dilution of secondary anti-rabbit HRP antibodies (Bio-Rad Laboratories) or 1:20,000 dilution (HIF1A) of secondary polyclonal anti-mouse alkaline phosphatase-conjugated antibodies (Sigma-Aldrich) for 1.5 h at 25.6°C. Immune complexes were visualized using Clarity Western ECL Substrate (Bio-Rad) or using alkaline phosphatase visualization procedure (HIF1A). Sample loading was standardized to expression of GAPDH (for PTGFR and MAPK1/3 quantification) or to expression of ACTB (for HIF1A quantification).
Real-time RT-PCR
RNA isolation and reverse transcription as well as analysis of gene expression in samples from in vivo and in vitro experiments were performed as described previously (Kaczynski & Waclawik 2013) . PTGFR and VEGFA gene expressions were quantified using Power SYBR Green (Life Technologies) with specific primers (1 µM; Table 2 ), whereas BGN, IL1A, IL6, MMP9, and TGFB3 genes were analyzed using TaqMan Master Mix with TaqMan probes (Life Technologies) according to the manufacturers' protocol. The PCR program for PTGFR and VEGFA genes was performed as follows: initial denaturation (95°C, 10 min) followed by 36 cycles of denaturation (95°C, 15 s), annealing and elongation (60°C, 1 min). For ACTB, PPIA, and GAPDH amplification, the PCR program was as follows: initial denaturation (95°C, 10 min) followed by 36 cycles of denaturation (95°C, 15 s), annealing (55°C, 30 s), and elongation (72°C, 1 min). Gene expression was estimated using realtime PCR Miner (http://ewindup.info/miner/) Software (Zhao & Fernald 2005) . Expression of genes analyzed in endometrial samples was normalized against the expression of ACTB (Kaczynski & Waclawik 2013) .
RIA for VEGFA
Concentrations of VEGFA secreted by endometrial explants to CM were measured as described previously (Berisha et al. 2000) . The intra-assay variation was 5.97%. The ED50 was 3.121 ng/µL. Dilution of samples containing endogenous VEGFA ran parallel to the standard curve. The average recovery of exogenous VEGFA was 95%.
Statistical analyses
Two-way ANOVA followed by Bonferroni post-tests was used to analyze data obtained from in vivo experiments. 
Results obtained from all in vitro experiments were analyzed by one-way ANOVA followed by Tukey's test. Differences were considered statistically significant at 95% CI level (P < 0.05). All statistical analyses were conducted using GraphPad Prism v. 5.02 Software (GraphPad Software, Inc.).
Results
The conceptus up-regulates PTGFR protein expression in porcine endometrium in vivo (Experiment 1)
Porcine conceptuses regulated PTGFR gene and protein expression in vivo. Endometrial PTGFR protein expression was approximately three-fold greater in the intact and isolated uterine horns of gilts on day 14 of pregnancy compared with its expression in the endometrium of intact and isolated horns of control gilts on day 14 of the estrous cycle (Fig. 1D ). The increase in PTGFR protein expression was observed both in intact and isolated horns and was not dependent on the direct presence of conceptuses (local action), suggesting a systemic effect of conceptuses on this receptor. In pigs on day 14 of the estrous cycle, mRNA expression of PTGFR in both uterine horns was higher (P < 0.05) compared with its expression in endometrium from intact and isolated horns in pregnant gilts (Fig. 1B) . No effect of conceptus (P > 0.05) was observed on endometrial PTGFR expression on day 11 of the estrous cycle and pregnancy ( Fig. 1A and C ).
E 2 stimulates PTGFR mRNA and protein expression in endometrium in vitro (Experiment 2)
Effect of E 2 on PTGFR mRNA expression in LE and ST cells of endometrium
As E 2 is the conceptus signal for maternal pregnancy recognition in pigs, we further studied whether the Figure 1 Effect of conceptus on prostaglandin F2α receptor (PTGFR) mRNA (A and B) and protein (C and D) expression in endometrium from the porcine in vivo unilateral model of pregnancy on days 11 and 14 after estrus. The control group consisted of gilts surgically operated but not inseminated (gilts on days 11 and 14 of the estrous cycle). Different letters (small letters for intact uterine horn and capital letters for isolated uterine horn) indicate statistically significant differences between cyclic and pregnant pigs (P < 0.05 Fig. 1A and B, see section on supplementary data given at the end of this article).
Effect of E 2 on PTGFR mRNA and protein expression in endometrial explants
It seemed likely that the in vitro model, which included only LE and ST cells cultured separately, could be distinct from physiological conditions. Therefore, we used endometrial tissue explants as a more appropriate model to study the effect of E 2 on PTGFR gene and protein expression in vitro. E 2 stimulated PTGFR mRNA and protein expression in porcine endometrial explants in vitro. The content of PTGFR mRNA increased 1.8-fold, whereas its protein content was elevated 1.6-fold after treatment with 1 and 100 nM E 2 (P < 0.05; Fig. 2A and B). 
E 2 elevates PTGFR protein expression in endometrium in vivo (Experiment 3)
As we determined that E 2 can increase PTGFR gene and protein content in endometrium, we further studied whether E 2 and/or PGE2, which is also secreted by the conceptus, regulate PTGFR expression in porcine endometrium in vivo. Greater levels of PTGFR protein were observed in endometrial samples collected from both horns of gilts receiving infusions of E 2 (833 ng/infusion) or vehicle compared with their expression in samples from vehicle-treated only horns in the control group (Fig. 2C ). PGE2 or a higher dose of E 2 administered alone did not exert statistically different effects. Simultaneous administration of E 2 together with PGE2 had no influence on PTGFR protein expression. Neither PGE2 nor E 2 administered alone or simultaneously had any effect (P > 0.05) on PTGFR gene expression in the samples examined ( Supplementary Fig. 2 ).
Immunolocalization of PTGFR protein in uterus (Experiment 4)
Localization of PTGFR protein was detected in LE cells and superficial glandular epithelial (GE) cells (Fig. 3A , C and E) in the deep GE cells (Fig. 3B, D and F ) and in the blood vessels (Fig. 3) . PTGFR protein was localized in tunica intima and media of arteries (marked in Fig. 3B and D) and in tunica intima only of larger veins and venules (marked in Fig. 3C , E and F). A weak signal for PTGFR expression was detected in ST cells and myometrium. The isotype control (negative control) confirmed the specificity of antibodies and is shown in the upper-right part of Fig. 3B .
PGF2α increases MAPK1/3 kinase phosphorylation in LE cells (Experiment 5)
As we showed PTGFR protein up-regulation by conceptuses and E 2 in porcine endometrium in vitro and in vivo, we decided to determine whether PGF2α acting on its receptor can activate the MAPK1/3 pathway. PGF2α (10 and 100 nM) increased (P < 0.05) phosphorylation of MAPK1/3 proteins two-fold in endometrial LE cells (Fig. 4A ). PGF2α-induced phosphorylation was abolished by addition of the MAPK1/3 inhibitor (PD098059).
PGF2α and its analog stimulate VEGFA synthesis and secretion by endometrial explants in vitro (Experiment 5)
As in human endometrial adenocarcinoma cells, PGF2α by activation of MAPK1/3 pathway enhanced expression of VEGFA (Sales et al. 2005) , we studied whether PGF2α present in the uterine lumen can stimulate synthesis and secretion of VEGFA in vitro. PGF2α (100 nM and 1 µM) and fluprostenol (100 nM) stimulated VEGFA gene expression (P < 0.05) in porcine endometrial explants in vitro (Fig. 4B) . RIA measurement of VEGFA concentration in conditioned CM revealed that both PGF2α (1 µM) and fluprostenol (100 nM and 1 µM) elevated secretion (P < 0.05) of VEGFA by porcine endometrial explants (Fig. 4C ).
PGF2α promotes endometrial endothelial cell proliferation (Experiment 6)
We further studied whether PGF2α-induced VEGFA synthesis and secretion by endometrium and conceptus cells can regulate endothelial cell proliferation. Primary endothelial cells isolated from PEE were characterized ( Supplementary Fig. 3 ). Similar to the immortalized swine umbilical vein endothelial cell line (G1410; Chrusciel et al. 2011) , PEE exhibited cobblestone morphology, and at 40-50% confluency, they started forming capillarylike tubules typical of endothelial cells ( Supplementary  Fig. 3A and B) . Moreover, we confirmed the presence of key markers of endothelial cells, VE-cadherin (CDH5), and VWF in PEE. CDH5 was observed only in cell membranes, whereas VWF was localized in cytoplasm ( Supplementary Fig. 3C , D, E and F). Using PEE isolated from porcine endometrium and the G1410 cell line, we found that conditioned media collected from endometrial explants treated with 1 μM PGF2α stimulated (P < 0.001) proliferation of these cells ( Fig. 5A and B) . Stimulation of both PEE and G1410 cells by PGF-CM was abolished using the selective, cell-permeable inhibitor of VEGF receptors (AAL993; P < 0.001). Co-treatment of endometrial explants with PGF2α and PTGFR inhibitors (AL8810) or adenylyl cyclase inhibitor (SQ22,536) abolished PGF2α-mediated effects on proliferation of PEE and G1410 cells (P < 0.05). VEGFA (50 ng/mL) and 20% NCS, used as positive controls, significantly elevated proliferation of PEE and G1410 cells to a similar extent as PGF-CM. We did not observe any direct effect of PGF2α or inhibitors alone on PEE and G1410 proliferation ( Supplementary Fig. 4A , B and C). AAL993 had no effect on HIF1A protein expression in the G1410 cell line (Supplementary Fig. 4D ).
PGF2α regulates expression of genes potentially important for embryo-maternal interactions (Experiments 5)
Additionally, we examined whether PGF2α can regulate the expression of genes potentially involved in other processes important for implantation, such as ECM and tissue remodeling, cell adhesion, or immune response. In porcine endometrial explants, 1 μM PGF2α elevated gene expression of BGN (Fig. 6A) , MMP9 (Fig. 6B) , TGFB3 (Fig. 6C) , and IL1α (IL1A; Fig. 6D ). A lower dose of PGF2α (100 nM) elevated expression of BGN and IL1A (P < 0.05). There was no effect of PGF2α (100 nM and 1 μM) on IL6 mRNA expression in porcine endometrial explants ( Supplementary Fig. 5 ).
Discussion
PGs are involved in the implantation of embryos as well as the proper development of early pregnancy in humans and other mammals (Geisert et al. 1982 , Weems et al. 2006 , Kennedy et al. 2007 , Ulbrich et al. 2009 , Waclawik et al. 2009 , Vilella et al. 2013 . Disrupted synthesis of PGs results in pregnancy loss in humans (Achache et al. 2010) and other animals such as pigs (Kraeling et al. 1985) , ruminants (Erdem & Guzeloglu 2010 , Dorniak et al. 2011 , and rodents (Kennedy et al. 2007 ). However, the types of PGs involved have not been definitely established in most studies, as general inhibitors of PG synthesis were used (Kennedy et al. 2007) . Mainly, PGE2 and/or PGI2 are believed to promote processes such as adhesion of human and porcine conceptus cells to ECM , decidualization in mice (Lim et al. 1999) , blastocyst hatching, and implantation (Huang et al. 2004 , Kennedy et al. 2007 . However, the possible role of high amounts of PGF2α secreted into the uterine lumen during early pregnancy in pigs and other species remains unresolved (Zavy et al. 1980 , Waclawik et al. 2006 , Kennedy et al. 2007 , Ulbrich et al. 2009 , Wang et al. 2010 , Vilella et al. 2013 , Kowalewski et al. 2014 . However, there are reports suggesting a detrimental role of this PG on blastocyst growth (Seals et al. 1998) and generally on the establishment of pregnancy because of the luteolytic action of exogenous PGF2α on the CL (Podany et al. 1982 , Pajor & Zsolnai 1984 , Romagnoli et al. 1993 , Seals et al. 1998 , Lemaster et al. 1999 ). Using a model of unilateral pregnancy, we demonstrated that the presence of conceptuses up-regulated the expression of PTGFR protein in the endometrium in vivo. PTGFR protein content was greater in the endometrium of pregnant gilts on day 14 in both the intact (gravid) and isolated (non-gravid) horns compared with the endometrium of the intact and isolated horns of control cyclic gilts. This result indicates that conceptus products may be transported by local blood and/or lymph circulation or systemic circulation to isolated uterine horn. Our finding implies a systemic manner of conceptus action and is in agreement with our findings showing up-regulation of PTGFR protein expression in porcine endometrium on day 15 of pregnancy (Kaczynski & Waclawik 2013) . It is also consistent with our recent results demonstrating the stimulatory effect of conceptus secretions on endometrial PTGFR gene expression in vitro (Kaczynski & Waclawik 2013) . Moreover, higher expression of PTGFR protein coincides with elevated expression of PGF2α synthase in porcine endometrium and conceptuses as well as greater concentrations of PGF2α in the uterine lumen of pregnant gilts during this period (Zavy et al. 1980 , Waclawik et al. 2006 , 2007 .
In studies on the mechanisms of maternal recognition of pregnancy in pigs, usually in vivo models of pseudopregnancy are used in which 5 mg of E 2 benzoate is administered systemically on days 11-15 of the estrous cycle, resulting in pharmacological concentrations of E 2 (Frank et al. 1977 , Geisert et al. 1982 , Pusateri et al. 1996 , Kawarasaki et al. 2012 . The novel approach applied in our study allowed us to examine both local and systemic effects of E 2 in concentrations close to the physiological levels secreted by embryos into the uterine lumen. This is the first report showing that intrauterine E 2 administration increased the abundance of PTGFR protein in porcine endometrium in vivo. Interestingly, PTGFR protein expression was up-regulated in both E 2 -treated and vehicle-treated uterine horns compared with the endometrium of vehicle-treated horns of control cyclic gilts. These findings correspond with the results obtained in this study using the unilateral model of pregnancy in vivo that indicate a systemic effect of E 2 administered into the uterine lumen. Moreover, this is in agreement with the finding that intrauterine infusion of E 2 can exert not only a local effect in the uterine horn into which it was administered but also a systemic effect, i.e., on the contralateral uterine horn or ovaries (Ford et al. 1982) . Accordingly, the in vitro experiment performed in this study demonstrated that E 2 stimulated PTGFR gene and protein expression in endometrial explants. These results support our previous findings indicating that the porcine conceptus can mediate its effects on PTGFR expression by estrogen receptor (Kaczynski & Waclawik 2013) . Similarly, up-regulation of PTGFR mRNA content by E 2 was observed in the uteri of rats (Yallampalli & Dong 2000) . In cattle, higher levels of PTGFR mRNA were detected in caruncles of placentomes, i.e., uterine tissue in direct contact with cotyledons of the placenta (Fortier et al. 2004) .
Immunolocalization of PTGFR protein in porcine uterus revealed its expression mainly in LE and GE and blood vessels, as well as in ST cells of porcine endometrium when examined on days 12 and 15 of pregnancy and day 12 of the estrous cycle. A similar distribution of PTGFR was observed in the ovine uterus (Dorniak et al. 2011) . Previously, we demonstrated the presence of PTGFR mRNA in LE and ST cells of the endometrium (Kaczynski & Waclawik 2013 ). The present results suggest that LE and GE cells have a greater potential to respond to PGF2α action than ST cells. Moreover, PTGFR expression in the tunica media of endometrial arteries suggests a vasoconstructive function of PGF2α. Differences in distribution of PTGFR protein in arteries and veins suggest possible differential function of PGF2α-PTGFR signaling in these vessels.
Our present results strongly support the hypothesis that PGF2α is a mediator of E 2 , the porcine conceptus signal www.reproduction-online.org
Reproduction (2016) 151 539-552 for recognition of pregnancy. In these in vivo and/or in vitro studies, we demonstrated that the conceptus and its signal, E 2 , elevated the expression of PTGFR protein in the endometrium. Our in vitro studies revealed that both PGF2α and its analog (fluprostenol) increased VEGFA gene expression and VEGFA protein secretion by porcine endometrium. Therefore, we suggest that PGF2α acting on via PTGFR in an autocrine/paracrine manner in porcine endometrium enhanced gene expression, protein synthesis, and secretion of VEGFA. Accordingly, elevated expression of VEGFA, FLT1, and KDR was reported in porcine endometrium during the implantation period compared with earlier stages of pregnancy and the estrous cycle (Kaczmarek et al. 2008) . Until now, there were no data concerning the effect of PGF2α on the MAPKs signaling in endometrial cells under normal physiological conditions. In this study, we demonstrated that PGF2α treatment activated the MAPK1/3 signaling pathway in porcine LE cells of the endometrium, which is probably involved in elevated synthesis and secretion of VEGFA by endometrial cells. Likewise, treatment of human adenocarcinoma (Ishikawa FPS) cells with PGF2α rapidly induced phosphorylation of MAPK1/3 via the PTGFR. This, in turn, resulted in an increase in VEGFA promoter activity, expression of VEGFA mRNA, and secretion of VEGFA protein (Sales et al. 2005) .
VEGFA can be involved in early placentation by stimulating endometrial and conceptus angiogenesis and regulation of vascular permeability in pigs. Endothelial cell proliferation is one of the processes required for angiogenesis. We suggest that PGF2α present in the uterine lumen during the implantation period mediates angiogenesis by indirect effects on the function of endometrial endothelial cells. The this study indicates that PGF2α stimulated endometrial secretion of VEGFA, which can act on blood vessels in a paracrine manner to promote proliferation of endothelial cells in endometrium. PGF-CM enhanced proliferation of PEE cells and the immortalized swine umbilical vein endothelial cell line (G1410). Using specific inhibitors of PTGFR and adenylyl cyclase, we demonstrated that the stimulatory effects of conditioned medium on proliferation of these endothelial cells were dependent on PGF2α-PTGFR and adenylyl cyclase signaling in endometrium. It was reported that in some cases, PGF2α could be a stimulator of cAMP production (Yamaguchi et al. 1988 , Tachado et al. 1993 . In turn, cAMP is also involved in VEGFA synthesis in human endometrium (Popovici et al. 1999) . In this study, co-treatment of endothelial cells with AAL993 and conditioned medium from PGF2α-treated endometrial explants abolished the stimulatory effect of PGF-CM on PEE and G1410 cell proliferation, which indicates involvement of VEGFA and its receptors in PGF2α-mediated proliferation of endothelial cells. Concordantly, an indirect effect of PGF2α in the promotion of angiogenic events was observed for human endometrial adenocarcinoma cell lines (Keightley et al. 2010) . Intriguingly, it can be suggested that PGF2α-stimulated synthesis of VEGFA by endometrial cells may not only be involved in angiogenic changes but also in stimulating proliferation and migration of porcine trophoblast cells (Jeong et al. 2014) .
Angiogenesis is not the only process regulated by PGF2α in the endometrium. We found that PGF2α upregulated expression of BGN, IL1A, MMP9, and TGFB3 genes in porcine endometrium. Processes accompanying the implantation period are controlled by a broad range of molecules. One of them is BGN, a protein belonging to the family of small leucine-rich proteoglycans (Iozzo & Murdoch 1996) . It is involved in endometrial ECM remodeling during decidualization in mice (San Martin et al. 2003) , cellular migration and adhesion, and regulation of growth factor availability and activity (Couchman et al. 1990 , Tufvesson & Westergren-Thorsson 2003 , Nastase et al. 2012 . Moreover, BGN can modulate inflammatory processes and induce secretion of IL1B (Nastase et al. 2012) . Up-regulation of BGN gene in endometrium by PGF2α suggests its involvement in ECM remodeling and immune interactions at the maternal-embryo interface.
Cell invasion is a result of active biochemical processes in which, among other enzymes, MMPs have been implicated (Bischof & Campana 2000) . In mouse endometrium, administration of MMPs inhibitors delays decidual remodeling and growth of ST cells (Alexander et al. 1996) . In tissues, expression of MMPs is usually low and is induced when ECM remodeling is required. It has also been reported that MMP9 by interaction with integrin AVB8 can activate latent TGFB (Mu et al. 2002) . In human adenocarcinoma cells, MMPs are associated with EGFR transphosphorylation, which results in elevated VEGFA expression (Sales et al. 2005) . Our findings suggest a regulation of MMP9 activity by PGF2α at the maternal-embryo interface. Elevated expression of MMP9 after PGF2α treatment in porcine endometrium may promote ECM remodeling, as well as augmenting stimulation of VEGFA synthesis by PGF2α.
TGFB is thought to mediate many key processes in reproduction, such as steroidogenesis, regulation of immunotolerance, embryogenesis, and tissue remodeling (Guzeloglu-Kayisli et al. 2009) . It is also an important cytokine regulating conceptus development and implantation in pigs (Blitek et al. 2013) . TGFβ stimulates fibronectin synthesis by porcine trophoblast as well as trophoblast cell adhesion to this protein (Jaeger et al. 2005) . Moreover, TGFβ together with tumor necrosis factor α stimulates MMP9 expression (Stuelten et al. 2005) . We determined that PGF2α up-regulated TGFB3 mRNA in porcine endometrium in vitro, which supports previous findings indicating the up-regulation of TGFB3 expression in porcine endometrium during early stage (days 10, 12, and 14) of gestation (Gupta et al. 1998) . Our results suggest that PGF2α can act as a conceptus Reproduction (2016) 151 539-552 www.reproduction-online.org signal mediator due to its ability to trigger TGFβ3 signaling in the endometrium. IL1A is a cytokine belonging to the IL1 superfamily. It is synthesized mostly by macrophages and is mainly known as a pro-inflammatory factor (Dinarello & Savage 1989) . It also promotes angiogenesis by activating the VEGF-KDR pathway (Salven et al. 2002) . In humans, IL1A is involved in changing endometrial structure during implantation and menstrual cycle (Singer et al. 1997 , Huang et al. 1998 . This cytokine regulates PG secretion in several organs and tissues (Takács et al. 1988) . In cattle, IL1A stimulates PGF2α synthesis and secretion by endometrium in vitro and in vivo (Tanikawa et al. 2005 , Majewska et al. 2010 . Our results indicate that PGF2α increased IL1A mRNA expression in porcine endometrium. Thus, it may be hypothesized that PGF2α self-regulates its synthesis by increasing IL1A mRNA expression in porcine endometrium.
In conclusion, this study presents the first comprehensive evidence for a role for PGF2α acting in an autocrine and/or paracrine manner through its receptor in the porcine endometrium during the peri-implantation period (Fig. 7) . Our results strongly support the hypothesis that PGF2α is a mediator of the embryonic signal for recognition of pregnancy in endometrium. In this study, the conceptus and its signal (E 2 ) elevated expression of endometrial PTGFR protein in endometrium both in vivo and in vitro. PGF2α, acting on PTGFR in an autocrine/paracrine manner in the porcine endometrium, enhanced synthesis and secretion of VEGFA. In turn, secreted VEGFA stimulated endometrial endothelial cell proliferation, which can promote angiogenesis at the maternal-conceptus interface during the implantation period in pigs. Moreover, regulation of BGN, MMP9, TGFB3, and IL1A gene expressions by PGF2α in the endometrium may promote endometrial remodeling and embryo-maternal communication during early pregnancy.
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